| Description | C-C motif chemokine ligand 22 | dipeptidyl peptidase 4 | 
    
      | Image | No pdb structure |  | 
    
 
     | Cellular Component |  |  | 
    
      | Molecular Function |  |  | 
    
      | Biological Process |  |  | 
    
      | Pathways |  |  | 
    
      | Drugs |  | 
                      AtorvastatinSitagliptin2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine(2s)-Pyrrolidin-2-Ylmethylamine4-Iodo-L-phenylalanineDiisopropylphosphono Group1-(1-phenylcyclopentyl)methylamine(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamideVildagliptinPSN9301AMG-222BisegliptinAlogliptinSaxagliptin(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINEN-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-oneMETHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE1-biphenyl-2-ylmethanamine(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINEN-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILEABT-341(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINEGosogliptinN-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILELinagliptinDutogliptin | 
    
      | Diseases |  |  | 
    
      | GWAS |  |  | 
    
	
    
				
    
      | Interacting Genes | 10 interacting genes:
                  AQP6
                  CCL14
                  CCL19
                  CCR4
                  CRYAB
                  DPP4
                  GCLC
                  HERC3
                  PF4V1
                  VCAM1 | 16 interacting genes:
                  ADA
                  CCL11
                  CCL22
                  CCL3L1
                  CCL5
                  CD4
                  CPAMD8
                  CXCL10
                  CXCL11
                  CXCL12
                  CXCL9
                  CXCR4
                  DKK1
                  FAP
                  GRP
                  PTPRC | 
				
    
      | Entrez ID | 6367 | 1803 | 
    
      | HPRD ID | 04263 | 02187 | 
    
      | Ensembl ID | ENSG00000102962 | ENSG00000197635 | 
    
      | Uniprot IDs | O00626 | A0A7I2V2X8 
                P27487 | 
    
      | PDB IDs |  | 1J2E 
                    1N1M 
                    1NU6 
                    1NU8 
                    1PFQ 
                    1R9M 
                    1R9N 
                    1RWQ 
                    1TK3 
                    1TKR 
                    1U8E 
                    1W1I 
                    1WCY 
                    1X70 
                    2AJL 
                    2BGN 
                    2BGR 
                    2BUB 
                    2FJP 
                    2G5P 
                    2G5T 
                    2G63 
                    2HHA 
                    2I03 
                    2I78 
                    2IIT 
                    2IIV 
                    2JID 
                    2OAG 
                    2OGZ 
                    2OLE 
                    2ONC 
                    2OPH 
                    2OQI 
                    2OQV 
                    2P8S 
                    2QJR 
                    2QKY 
                    2QOE 
                    2QT9 
                    2QTB 
                    2RGU 
                    2RIP 
                    3BJM 
                    3C43 
                    3C45 
                    3CCB 
                    3CCC 
                    3D4L 
                    3EIO 
                    3F8S 
                    3G0B 
                    3G0C 
                    3G0D 
                    3G0G 
                    3H0C 
                    3HAB 
                    3HAC 
                    3KWF 
                    3KWJ 
                    3NOX 
                    3O95 
                    3O9V 
                    3OC0 
                    3OPM 
                    3Q0T 
                    3Q8W 
                    3QBJ 
                    3SWW 
                    3SX4 
                    3VJK 
                    3VJL 
                    3VJM 
                    3W2T 
                    3WQH 
                    4A5S 
                    4DSA 
                    4DSZ 
                    4DTC 
                    4G1F 
                    4J3J 
                    4JH0 
                    4KR0 
                    4L72 
                    4LKO 
                    4N8D 
                    4N8E 
                    4PNZ 
                    4PV7 
                    4QZV 
                    5I7U 
                    5ISM 
                    5J3J 
                    5KBY 
                    5T4B 
                    5T4E 
                    5T4F 
                    5T4H 
                    5Y7H 
                    5Y7J 
                    5Y7K 
                    5ZID 
                    6B1E 
                    6B1O 
                    8WKU 
                    8ZDX 
                    8ZE6 | 
    
      | Enriched GO Terms of Interacting Partners? |  |  | 
    
      | Tagcloud ? |  |  | 
    
      | Tagcloud (Difference) ? |  |  | 
    
      | Tagcloud (Intersection) ? |  |